Olema Pharmaceuticals (NASDAQ:OLMA) Now Covered by Analysts at Oppenheimer

Stock analysts at Oppenheimer began coverage on shares of Olema Pharmaceuticals (NASDAQ:OLMA – Get Free Report) in a note issued to investors on Thursday, FlyOnTheWall reports. The firm set an “outperform” rating on the stock. A number of other equities analysts have also weighed in on OLMA. HC Wainwright dropped their price target on shares […]

Related Keywords

Cyrus Harmon ,Jpmorgan Chase Co ,Blackrock Inc ,Sectoral Asset Management Inc ,Renaissance Technologies ,Olema Pharmaceuticals Inc ,Olema Pharmaceuticals ,Hedge Funds Weigh In On Olema Pharmaceuticals ,Millennium Management ,News Ratings For Olema Pharmaceuticals Daily ,Securities Exchange Commission ,Olema Pharmaceuticals Company Profile ,Olema Pharmaceuticals Trading Down ,Get Free Report ,One Financial ,Lifesci Capital ,Pharmaceuticals Trading Down ,Director Cyrus Harmon ,Exchange Commission ,Asset Management ,Olema Pharmaceuticals Daily ,